A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma

Figure 1

Genetic changes in ADAMTSs across cancer types. (a) The CNV frequency of the ADAMTSs (gain). (b) The CNV frequency of the ADAMTSs (loss). (c) The SNV frequency of the ADAMTSs. (d) Difference of methylation of ADAMTSs between tumor and normal tissue. (e) Correlation between methylation of ADAMTSs and gene expression. (f) The relationship between methylation of ADAMTSs and overall survival rate.

(a)

(b)

(c)

(d)

(e)

(f)